Prognostic value of the cyclin-dependent kinase inhibitor p27Kip1 in gastric cancer

被引:0
|
作者
Müller, W
Grabsch, H
Takeno, S
Noguchi, T
Hommel, G
Gabbert, HE
机构
[1] Univ Dusseldorf, Inst Pathol, D-40225 Dusseldorf, Germany
[2] Univ Mainz, Inst Med Stat, D-6500 Mainz, Germany
关键词
p27; gastric cancer; prognosis; cell cycle;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the present study, the expression and prognostic role of p27 were immunohistochemically investigated in 413 curatively resected gastric carcinomas. Strong p27 expression in more than 50% of the armour cells could be detected in 57.4% (n=237) whereas 42.6% of the tumours (n=176) only showed p27 expression in less than 50% of the tumour cells. No significant col-relation could be observed between p27 expression and the prognostic parameters pT category, pN category, blood and lymphatic vessel invasion as well as with tumour histology. Concerning other cell cycle associated proteins, p27 expression was inversely correlated with p21 expression, however; there was no correlation either with cyclin DI and cyclin E or with expression of p53, bcl-2 and tumour cell proliferation. Univariate survival analysis revealed a poorer prognostic outcome for patients with armours expressing p27 in more than 50% of the tumour cells (p<0.049). However; by multivariate analysis, this prognostic influence of p27 could not be verified as independent from the known prognostic parameters of the pTNM-system (p<0.325). The present data on 413 curatively resected gastric carcinomas suggest, that expression of p27, analyzed alone or in combination with multiple cell cycle regulatory proteins, has no prognostic value in gastric cancer.
引用
收藏
页码:1787 / 1792
页数:6
相关论文
共 50 条
  • [21] Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 in oval malignant tumors
    Ito, R
    Yasui, W
    Ogawa, Y
    Toyosawa, S
    Tahara, E
    Ijuhin, N
    PATHOBIOLOGY, 1999, 67 (04) : 169 - 173
  • [22] The cyclin-dependent kinase inhibitor p27KIP1 is mandatory for tolerance induction in vivo.
    Li, LQ
    Berezovskaya, A
    Boussiotis, VA
    BLOOD, 2005, 106 (11) : 227A - 227A
  • [23] Adenoviral expression of the cyclin-dependent kinase inhibitor p27Kip1:: a strategy for breast cancer gene therapy
    Rakkar, ANS
    Li, ZW
    Katayose, Y
    Kim, M
    Cowan, KH
    Seth, P
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (23) : 1836 - 1838
  • [24] Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma
    Tsihlias, J
    Kapusta, LR
    DeBoer, G
    Morava-Protzner, I
    Zbieranowski, I
    Bhattacharya, N
    Catzavelos, GC
    Klotz, LH
    Slingerland, JM
    CANCER RESEARCH, 1998, 58 (03) : 542 - 548
  • [25] The cyclin-dependent kinase inhibitor p27Kip1 induces N-terminal proteolytic cleavage of cyclin A
    Bastians, H
    Townsley, FM
    Ruderman, JV
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) : 15374 - 15381
  • [26] Expressions and localization of cyclin D1 and cyclin-dependent kinase inhibitor P27Kip1 in gliomas and meningiomas
    Ahmad, Farizan
    Abdullah, Jafri Malin
    Jaafar, Hasnan
    BIOMEDICAL RESEARCH-INDIA, 2009, 20 (02): : 109 - 114
  • [27] E-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27KIP1
    St Croix, B
    Sheehan, C
    Rak, JW
    Florenes, VA
    Slingerland, JM
    Kerbel, RS
    JOURNAL OF CELL BIOLOGY, 1998, 142 (02): : 557 - 571
  • [28] Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer
    Motti, ML
    De Marco, C
    Califano, D
    Fusco, A
    Viglietto, G
    CELL CYCLE, 2004, 3 (08) : 1074 - 1080
  • [29] Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27kip1 in hepatocellular carcinoma
    Ke-Jun Nan Zhao Jing Ling Gong Department of Medical Oncology
    World Journal of Gastroenterology, 2004, (10) : 1425 - 1430
  • [30] Cyclin-dependent kinase inhibitor (CDKI) p27KIP1 in CNS normal tissue and neoplasms.
    Giangaspero, F
    Morigi, P
    Naldi, S
    Cerasoli, S
    Bufalini, O
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (05): : 470 - 470